Dividend wala 🇮🇳

@Tradewith_kd Negative for crude re

Positive for Oil💥 JUST IN: 🇸🇦 Saudi Arabia's East-West oil pipeline bypassing the Strait of Hormuz is now pumping at full capacity of 7 million barrels per day.

@dave_janak Brother Gulf lnew abt war.they are benefitted due to crude Its all pre planned

માનો કે ના માનો, જિયોપોલિટિકલ રીતે વિશ્વમાં નવા સમીકરણો બની રહ્યા છે… સ્થિતિને સમજો કે ઈરાને જે દેશો પર હુમલા કરી ભયાનક નુકસાન પહોંચાડ્યું છે એ ખાડી દેશો ઈરાન સામે કાર્યવાહી કરવા તૈયાર નથી. આ દેશો ટ્રમ્પથી નારાજ છે, કહી રહ્યા છે કે અમને વિશ્વાસમાં લીધા વગર જ ઈરાન પર હુમલો કરવામાં આવ્યો. અમેરિકી બેઝ માટે જગ્યા એટલે જ આપવામાં આવી હતી કે અમેરિકા તેમની રક્ષા કરે પરંતુ, અમેરિકા એમાં સંપૂર્ણપણે નિષ્ફળ રહ્યું છે. કતારના રોયલ ફેમિલીએ ટ્રમ્પને વિમાન પણ ગિફ્ટ કર્યું હતું એ યાદ છે ને ! સામે સુરક્ષા ના મળવાથી કતારથી લઈ બાકી ખાડી દેશો નારાજ છે. આ ખાડી દેશોનું અમેરિકામાં મોટું રોકાણ છે… આ રોકાણ પાછું લેવાય તો પણ અમેરિકા ઘૂંટણિયે આવી જાય. #IranWar | #Trump

@alok_arg @DrVNMishraa Bhaiya sub jagah ka halat yahi he Even #ahmedabad me petrol crisis me bhi reel baaz kafi the . Sirf reel k liye .. Pata nahi kya dopamine milta he unko #Israël

@DrVNMishraa रील वीडियो बनाने वालो ने ही बहुत ज्यादा भीड़ बढ़ा दिया है काशी केदारनाथ बद्रीनाथ जैसे अन्य धार्मिक जगहों या घूमने फिरने की जगहों पर।

सावधान! देखते देखते काशी का नया इतिहास लिख रहे हैं, फेसबुकिये रिलिये! काशी के हर व्यक्ति हर जगह को संदिग्ध बता के लाइक्स बढ़वा रहे!

1. કલમ 125(a) અને 125(b): બીજાના જીવન કે વ્યક્તિગત સુરક્ષાને જોખમમાં મૂકવી ​આ કલમ અગાઉની IPC ની કલમ 336, 337 અને 338 જેવી જ છે. ​125(a): જ્યારે કોઈ વ્યક્તિ ઉતાવળ કે બેદરકારીભર્યું કાર્ય (Rash or Negligent Act) કરીને અન્ય કોઈ વ્યક્તિને સામાન્ય ઈજા (Hurt) પહોંચાડે છે, ત્યારે આ કલમ લાગે છે. ​સજા: 6 મહિના સુધીની જેલ અથવા ₹5,000 સુધીનો દંડ, અથવા બંને. ​125(b): જ્યારે આવા જ બેદરકારીભર્યા કાર્યથી કોઈ વ્યક્તિને ગંભીર ઈજા (Grievous Hurt) પહોંચે (જેમ કે હાડકું તૂટવું અથવા કાયમી ખોડખાંપણ), ત્યારે આ કલમ લાગુ થાય છે. ​સજા: 3 વર્ષ સુધીની જેલ અથવા ₹10,000 સુધીનો દંડ, અથવા બંને. ​2. કલમ 281: જાહેર માર્ગ પર પૂરઝડપે અથવા બેદરકારીથી વાહન ચલાવવું ​આ કલમ જૂની IPC ની કલમ 279 નું નવું સ્વરૂપ છે. ​જો કોઈ વ્યક્તિ જાહેર રસ્તા પર એવી રીતે વાહન ચલાવે કે જેનાથી માનવ જીવન જોખમમાં મુકાય અથવા અન્ય કોઈને ઈજા થવાની સંભાવના હોય. ​સજા: 6 મહિના સુધીની જેલ અથવા ₹1,000 સુધીનો દંડ, અથવા બંને. ​3. કલમ 324(4): મિલકતને નુકસાન અથવા ખોટી રીતે નુકસાન પહોંચાડવું ​આ કલમ "Mischief" (નુકસાન) સાથે સંબંધિત છે. ​કલમ 324 સામાન્ય રીતે મિલકતને નુકસાન પહોંચાડવાની વાત કરે છે. પેટા-કલમ (4) મુજબ જો નુકસાનની રકમ અથવા પ્રકૃતિ ગંભીર હોય (ચોક્કસ રકમથી વધુ), તો તે શિક્ષાપાત્ર બને છે. ​મોટર વ્હીકલ એક્ટ (MVA) ની કલમો ​1. કલમ 177: સામાન્ય ગુનાઓ માટે દંડ ​આ એક "General Provision" છે. જો મોટર વ્હીકલ એક્ટના કોઈ એવા નિયમનો ભંગ થયો હોય જેના માટે અલગથી કોઈ ચોક્કસ સજા નક્કી કરવામાં આવી નથી, તો આ કલમ હેઠળ દંડ વસૂલવામાં આવે છે. ​સજા: પ્રથમ વખત માટે ₹500 અને બીજી વખત માટે ₹1,500 સુધીનો દંડ થઈ શકે છે. ​2. કલમ 184: જોખમી રીતે વાહન ચલાવવું (Dangerous Driving) ​આ કલમ ખૂબ જ ગંભીર છે. જો તમે લાલ લાઈટ જમ્પ કરો છો, ચાલુ વાહને મોબાઈલ વાપરો છો, ખોટી રીતે ઓવરટેક કરો છો કે વન-વેમાં વિરુદ્ધ દિશામાં ગાડી ચલાવો છો, તો આ કલમ લાગે છે. ​સજા: પ્રથમ વખત ₹1,000 થી ₹5,000 સુધીનો દંડ અથવા 6 મહિનાથી 1 વર્ષની જેલ. ​3. કલમ 134(b): અકસ્માતના કિસ્સામાં ડ્રાઈવરની ફરજ ​જ્યારે કોઈ અકસ્માત થાય, ત્યારે ડ્રાઈવરની જવાબદારી બને છે કે: ​ઈજાગ્રસ્ત વ્યક્તિને તબીબી સારવાર મળે તે માટે મદદ કરવી (સિવાય કે ભીડ દ્વારા હુમલો થવાનો ડર હોય). ​134(b) મુજબ: અકસ્માતની જાણ નજીકના પોલીસ સ્ટેશનમાં 24 કલાકની અંદર કરવી ફરજિયાત છે. જો ડ્રાઈવર પોલીસને જાણ કર્યા વગર ભાગી જાય, તો આ કલમ હેઠળ ગુનો નોંધાય છે.

હદ છે યાર… કેવો હશે આ માણસ… બાઈક સવારને ટક્કર મારીને ભાગ્યો. વિચારો ગાડીની સ્પીડ કેવી હશે કે ગાડીના બોનેટમાં બાઈક ફસાઈ ગયું. આ વ્યક્તિ પર કાર્યવાહી થવી જોઈએ. @AhmedabadPolice | @dcptrafficwest | #Ahmedabad

@sagar_lele Bhai usne tere lele

Got a rickshaw for 240 on Uber He asked for 260 I asked him to cancel Booked a Rapido for 270 The same guy showed up with a grin Sat and started the ride His rickshaw broke down after 5 minutes Fare showed 36 He asked for 50 Paid him 50 He started the auto and sped away Wtf is even happening

આપણા #Ahmedabad માં સેકરીન વગરના, કેમિકલ ફ્રી ગોલા ક્યાં મળશે? #gujarat #india #जय_श्री_राम

@themahavir Bhai u r wrong here mf me investment campaign de nahi aaya ki MF sahi he Return dikha kar and comparison karke Ab usme bhi last 2 year se return nahi he mf me Yahi halat raha mf me to sare wapis LIC ki taraf jayenge . Kam se kam safe 5.5% return to mil rha he

My neighbour puts 11 Lakh into LIC every year. I thought it must be mis-selling. But when I probed, nobody mis-sold him. He has done this by choice. He proudly says that so many weddings have been funded by LIC payouts. He doesn’t care about low returns. He happily calls it “sovereign-backed safety”. This is a not an uneducated man. He is a successful businessman who knows his math. This feels like 1990s still running in 2025. When LIC was set up, the government needed to mobilize long-term savings from aam junta that relied on cash, gold, and land. Life insurance became that "vehicle", that "story". It worked. People saved. The government got long-term capital for development. But the side effect? LIC became shorthand for "investment." Not protection. Not security. Investment. That mindset never corrected. And it created two problems that persist today. A massive section of India's population genuinely does not understand why insurance shouldn't return money. "Paise wapas nahi milenge?" is still the first question. Even those who do understand pure protection, many still approach insurance with the mindset of "extracting" value back from the insurer. Let me take a term insurance till 85, so that claim is "guaranteed" India needs a campaign as big as the polio “Do Boond Zindagi Ke” to finally kill the mindset that insurance = investment.

@raghavwadhwa @grok explain in shorter note point by point but not greater than 10 points.

India’s Semaglutide Story Is Not Just About Diabetes. It’s About Pricing Disruption. After India’s patent expiry, generic launches have entered the market at prices up to ~70% lower than Novo’s original products. Novo’s Ozempic and Wegovy in India were roughly in the ₹8,800 to ₹11,000+ per month range. In comparison, Indian launches are now appearing anywhere from roughly ₹750 to ₹4,200, depending on the company, dose, format, and device positioning. 1⃣Now Look at Indian Launches 🔹Sun: ₹750 to ₹2,000 (per weekly dose depending on strength) 🔹Glenmark: ₹1,300 to ₹1,760 (per weekly dose) 🔹Zydus: ₹2,200 (reported price; varies by dose and device format) 🔹Eris/Natco: ₹1,290 (per weekly dose; vial format) 🔹Alkem: from ₹1,800 (reported price; varies by dose) 🔹Torrent: ₹3,999 (reported price; device-led, likely monthly equivalent) 🔹Dr Reddy’s (Obeda): ₹4,200 (per month; pre-filled pen) 2⃣This Changes the Debate Completely Once a therapy moves from ₹10,000 a month to ₹1,500 to ₹3,000 a month, the market is no longer about brand substitution. It becomes about demand unlocking. And that is the big thing many people are missing. 3⃣Why the Typical Pharma Framework Fails Here Most investors are still analysing semaglutide in India like a classic generic pharma event: Patent expires → multiple entrants → prices fall → margins compress. That framework is too simplistic. Because semaglutide in India was not sitting in a fully penetrated market waiting for cheaper competition. It was sitting in a market with massive disease burden but very low affordability-led penetration. 4⃣The Real Market Size Is Hidden in Affordability India already has around 89.8 million adults living with diabetes, and this number is expected to rise to 156.7 million by 2050. On the obesity side, the long-term burden is even larger, with around 254 million adults with generalised obesity and 351 million with abdominal obesity. This is not just a substitution story from Novo to generics. This is a market creation story driven by affordability. 5⃣Where Will Value Actually Accrue? Not equally across the value chain. API manufacturing may see the fastest commoditisation if too many players enter. Plain formulations may benefit from volume growth, but differentiation will be limited. Devices may hold better economics because patient comfort, convenience, dosing accuracy, and adherence matter significantly in chronic therapies. Distribution and doctor trust may be the most underrated moat, because this is not a one-time prescription category. This is a long-term therapy where continuity matters. 6⃣Competition Will Be Brutal Competition is going to intensify rapidly. Reuters suggests that more than 40 Indian companies could launch over 50 brands in this space. That is both the opportunity and the warning sign. The opportunity is clear. The Indian semaglutide market is now expected to grow from around ₹15 billion to nearly ₹80 billion by 2030. That is not just expansion. That is category creation. 7⃣But Not Everyone Will Win In markets like this, the first wave gets attention. The second wave decides margins. As more players enter and capacity builds, pricing pressure will accelerate, especially in low-differentiation formats like vials. Not every company entering this space will create shareholder value. 8⃣The Underappreciated Angle: Exports This is not just an India story. Indian pharma companies are already looking at markets such as Canada, Brazil, Latin America, and Turkey. This matters because India can become a low-cost manufacturing base for global price-sensitive markets. So the real question is not just who wins India. It is who uses India as a platform to scale globally. 9⃣Risks That Cannot Be Ignored This is not a straight-line opportunity. Pricing pressure can become too aggressive, especially in plain generic formats. Regulatory scrutiny is already increasing. CDSCO has inspected multiple entities and acted against unauthorised sales, misleading promotions, and irregular distribution practices. Compliance and channel discipline may become far more important than many investors currently expect. There is also innovation risk. Globally, newer obesity therapies, next-generation GLP-1 drugs, and improved delivery systems are already being developed. This could reshape the competitive landscape again over the next few years. 📌Final Takeaway On the surface, this may look like a generic price war. But underneath, it is the emergence of a massive chronic metabolic category moving from premium to accessible. Over the next three to five years, the biggest winners may not be the cheapest players. They are more likely to be companies that combine scale, device quality, doctor trust, patient adherence economics, export optionality, and regulatory discipline. The molecule may commoditise. But the market may not. And that is where the real value will be created. 📌Disclaimer: For educational purposes only.

@KVRM_X @Ravisutanjani 🚨 Completed 110000 KMs on Fiat padmini • Bumper Traffic: Didn’t really face much • Mixed: 14–16 km/l • Highway: 17–20 km/l Best Mileage at 4th gear & 80–85 km/h Fully satisfied with drive & ownership experience 👍 #Panamá #indiawins

@Ravisutanjani 🚨 Completed 11000 KMs on Tata Nexon CNG • Bumper Traffic: Didn’t really face much • Mixed: 14–16 km/l (petrol), 22–24 km/kg (CNG) • Highway: 17–20 km/l (petrol), 28–29 km/kg (CNG) Best Mileage at 5th gear & 80–85 km/h Fully satisfied with drive & ownership experience 👍

🚨 Completed 6000 KMs on XUV 3XO (TGDi) • Bumper Traffic : 12-14 km/l • Mixed : 14-16 km/l • Highway: 17-20 km/l Best Mileage at 6th Gear and 80-100 Speed Fully Satisfied with Drive & Ownership Experience

@Mitesh_Engr Ghonchu logo Woh current financial year ki bat kar rha he. Next FY se wapis chalu kar dega trader always be trader.

No trades for this FY now. Long break

@sunnysweet201 Dnt put all eggs in one basket. Life insurance is also have in ur bucket

લાઇફ ઇન્સ્યોરન્સ અને સેવિંગ એક સાથે હોય એવી કોઈ પણ સ્કીમમાં ક્યારેય રોકાણ કરવું ના જોઈએ..

@Sia_India_ @drprashantmish6 Did nt say killing the dogs Baka ,me bola punishment k liye Yeh tumhari ghatiya soch he ki killing karo.. Baap re.. Lagta he Psycho ho yaar tum

@devangsheth999 @drprashantmish6 Look who is talking about changing the social circle ,a sociopath who believes in killings animals .

Government should start Ladla Kutta Yojana, all the dog lovers who keep stray dogs at their home should get Rs.101 per month in this scheme and 50% reservation in veterinary colleges seat ( to family members) Benefits 1- Dogs related problem will be solved . 2- Dog lovers will be happy 3- Their family members can join veterinary college and they can treat those dogs also . 4- we can walk freely on roads without fear , walking is good for health . 5 -Nirmala Tai may propose dog cess for Ladla Kutta Yojana in the next budget ( additional revenue generation )

@Sia_India_ @drprashantmish6 Bhai tera mindset cruel ho gaya he aise logo ke sath reh ker. Apna circle change ker le #sincerão

@devangsheth999 @drprashantmish6 It’s the cruel mindset of ppl like you tht India is going to Stone Age,ppl like you who want voiceless to be killed r clearly sociopaths who just want to live for themselves Also not seen any rapists/ killers being Jailed so please wake up.

Baka ,who told u ..ki jail nahi hui he Kisi ek ko bhi.. Bhai kisi kutte ka suna he ki usko deth penalty di ho ??? Bhai tum apna mindset badlo Ek pune me female ko dogs ne bite kerke death kar diya and u told ki india me kitno ke sath rape hota he usme kya penalty hoti he. #india

@Sia_India_ @drprashantmish6 Tum jaiso ke mindset ki wajah se aaj Hamara india itna piche he. Usne murder kiya to me bhi karunga yej mindset he tumhara. Ek mistake kare to hum bhi kare. Rapist ko to punishment milti he ,dogs ko milti he kya?? Beta jis per gujarti he usko puch. #india #mumbai #pune #dog

@devangsheth999 @drprashantmish6 Today and everyday I see news of girls getting raped and killed on spot #india #rapes

@CNBC_Awaaz @_anujsinghal Bhai ne bola aur ulta hua.. Yeh bole uska ulta karo

#EditorsTake। निफ्टी: कितना गिर सकते हैं हम? इस रैली का शुरुआती प्वाइंट हमने 22,000 माना 22,000 से 26,300 तक करीब 4300 अंकों की रैली हुई उसमें से अब हम लगभग 75% गंवा चुके हैं ऐसे में 22,000 तक का रिस्क ओपन रहेगा @_anujsinghal #AwaazMarkets

@gujratsamachar RIP 🙏

'સૌને માફ કરીને અને સૌની માફી માગીને હવે જાઓ...', હરીશ રાણાની અંતિમ ક્ષણો રડાવી દેશે #HarishRana #Ghaziabad #Euthanasia #SupremeCourtIndia #AIIMS #EmotionalVideo #FinalFarewell #LastGoodbye #GujaratSamachar

@Curious_Com_ @grok verify this

🚨 BIG BREAKING : Iran opens the Strait of Hormuz to all countries except the USA, Israel and allies. 🇮🇳 BIG POSITIVE FOR INDIA

@nidhirpatel6 Share video